Cited by 39Pancreatic function and diabetesNeuropeptides and Animal PhysiologyDiabetes Treatment and Management

Neuromedin U receptor 1 expression in the rat endocrine pancreas and evidence suggesting neuromedin U suppressive effect on insulin secretion from isolated rat pancreatic islets

Open access
Kaczmarek, Przemyslaw, Malendowicz, Ludwik, Pruszynska-Oszmalek, Ewa, Wojciechowicz, Tatiana, Szczepankiewicz, Dawid, Szkudelski, Tomasz, Nowak, Krzysztof·2006·International Journal of Molecular Medicine

Abstract

Neuromedin U (NmU) is a regulatory peptide found in significant concentrations in both the brain and gut of the rat and is named according to its ability to powerfully contract the uterus. Two types of NmU receptors were recently identified and subsequent studies evidenced NmU involvement in the regulation of energy homeostasis. Such a role of neuromedin U suggests that a polypeptide may also be involved in the regulation of adipoinsular axis function. Therefore in the present study we examined the expression of NmU receptors in pancreatic islets using RT-PCR and Western blotting analysis. We also investigated the role of NmU in regulation of insulin secretion in vitro using isolated pancreatic islets. We have confirmed that NmUR1 but not NmUR2 is specifically expressed in isolated rat pancreatic islets. In all tested doses (1, 10, 100 nmol/l) NmU dose- dependently decreased insulin output by isolated pancreatic islets. These inhibitory effects of NmU on insulin secretion may suggest the involvement of NmU in regulating the pancreatic branch of adipoinsular axis function. Thus, NmU can be included in that group of anorectic peptides, which are also involved in the regulation of insulin secretion.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3892/ijmm.18.5.951

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • NmU likely regulates insulin secretion; NmUR1 is expressed in pancreatic islets and its stimulation dose-dependently decreased insulin release.

    “In addition to this, NmU is likely to regulate insulin secretion; the G-protein-coupled NmU receptor 1 (NmUR1) is expressed in pancreatic islets and its simulation dose dependently decreased insulin release.230, 231”

    From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [230]

    The Results report NmUR1 expression in rat pancreatic islets and a dose-dependent decrease in insulin output when isolated islets were treated with NmU. The Discussion cautions that this effect may not be directly connected to NmUR1 signaling in beta cells, so the paper does not establish that stimulation of NmUR1 itself caused the decrease. (LLM, conf=0.87)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 26 · Cited by 39

Research works printed but not linked: 1

  1. Hanada R, Teranishi H, Pearson JT, et al: Neuromedin U has a novel anorexigenic effect independent of the leptin signaling pathway. Nat Med 10: 1067-1073, 2004.

Authors
Kaczmarek, P., Malendowicz, L., Pruszynska-Oszmalek, E., Wojciechowicz, T., Szczepankiewicz, D., Szkudelski, T., & Nowak, K.
Affiliations
Poznan University of Medical Sciences (PL)
Venue
International Journal of Molecular Medicine
Published
2006-11-01
Volume
18
Issue
5
Pages
951-5
ISSN
  • 1107-3756 (ISSN-L)
  • 1791-244X
OpenAlex
W2037502126
Cited by
39
References
26
Citations by year
2024: 1 · 2022: 1 · 2021: 4 · 2020: 3 · 2019: 5 · 2018: 4 · 2017: 3 · 2016: 1 · 2015: 5 · 2013: 2 · 2012: 1
FWCI
2.38
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
neuromedin U, pancreatic islets, insulin secretion, energy homeostasis, anorectic peptides, endocrine pancreas, receptor expression
MeSH terms
Insulin Secretion, Animals, Appetite Depressants, Insulin, Insulin Antagonists, Islets of Langerhans, Membrane Proteins, Neuropeptides, RNA, Messenger, Blotting, Western, Receptors, Neurotransmitter, Reverse Transcriptase Polymerase Chain Reaction, Rats, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review